There is still no perfect treatment suggestion for patients with asymptomatic colorectal cancer with unresectable metastatic disease. Whether patients can benefit from palliative resection of primary tumor or not is still waiting for answer. The investigators hypothesis that asymptomatic metastatic colorectal cancer patients who respond to chemotherapy will benefit from primary tumor resection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
480
Surgical resection of primary tumor of mCRC patients who were respond to first line chemotherapy'
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
RECRUITINGOverall survival
Time frame: 3 years
Number of Participants with Adverse Events both in surgery group and chemotherapy group
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.